These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25745996)

  • 1. Inactivation of the retinoblastoma gene yields a mouse model of malignant colorectal cancer.
    Parisi T; Bronson RT; Lees JA
    Oncogene; 2015 Nov; 34(48):5890-9. PubMed ID: 25745996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinoma.
    Zhang MQ; Chen ZM; Wang HL
    Mod Pathol; 2006 Apr; 19(4):573-80. PubMed ID: 16501564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells.
    Guo L; Zhong D; Lau S; Liu X; Dong XY; Sun X; Yang VW; Vertino PM; Moreno CS; Varma V; Dong JT; Zhou W
    Mol Cancer Res; 2008 Sep; 6(9):1421-30. PubMed ID: 18819930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
    Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model.
    Batisse-Lignier M; Sahut-Barnola I; Tissier F; Dumontet T; Mathieu M; Drelon C; Pointud JC; Damon-Soubeyrand C; Marceau G; Kemeny JL; Bertherat J; Tauveron I; Val P; Martinez A; Lefrançois-Martinez AM
    Oncogene; 2017 Aug; 36(31):4445-4456. PubMed ID: 28368424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer.
    Zhou Z; Flesken-Nikitin A; Corney DC; Wang W; Goodrich DW; Roy-Burman P; Nikitin AY
    Cancer Res; 2006 Aug; 66(16):7889-98. PubMed ID: 16912162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model.
    Hill R; Song Y; Cardiff RD; Van Dyke T
    Cancer Res; 2005 Nov; 65(22):10243-54. PubMed ID: 16288012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition.
    Martin P; Liu YN; Pierce R; Abou-Kheir W; Casey O; Seng V; Camacho D; Simpson RM; Kelly K
    Am J Pathol; 2011 Jul; 179(1):422-35. PubMed ID: 21703421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of metastatic site on the expression of CEA and cellular localization of β-catenin in colorectal cancer.
    Rao US; Hoerster NS; Thirumala S; Rao PS
    J Gastroenterol Hepatol; 2013 Mar; 28(3):505-12. PubMed ID: 23216017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis.
    Giles RH; Lolkema MP; Snijckers CM; Belderbos M; van der Groep P; Mans DA; van Beest M; van Noort M; Goldschmeding R; van Diest PJ; Clevers H; Voest EE
    Oncogene; 2006 May; 25(21):3065-70. PubMed ID: 16407833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.
    Semczuk A; Marzec B; Roessner A; Jakowicki JA; Wojcierowski J; Schneider-Stock R
    Virchows Arch; 2002 Dec; 441(6):577-83. PubMed ID: 12461615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19+- liver cells deficient for p53 and Rb.
    Matondo RB; Toussaint MJ; Govaert KM; van Vuuren LD; Nantasanti S; Nijkamp MW; Pandit SK; Tooten PC; Koster MH; Holleman K; Schot A; Gu G; Spee B; Roskams T; Rinkes IB; Schotanus B; Kranenburg O; de Bruin A
    Oncotarget; 2016 Aug; 7(34):54662-54675. PubMed ID: 27323406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue.
    Wang Y; Hayward SW; Donjacour AA; Young P; Jacks T; Sage J; Dahiya R; Cardiff RD; Day ML; Cunha GR
    Cancer Res; 2000 Nov; 60(21):6008-17. PubMed ID: 11085521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma.
    Schaffer BE; Park KS; Yiu G; Conklin JF; Lin C; Burkhart DL; Karnezis AN; Sweet-Cordero EA; Sage J
    Cancer Res; 2010 May; 70(10):3877-83. PubMed ID: 20406986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of beta-catenin is common in canine sporadic colorectal tumors.
    McEntee MF; Brenneman KA
    Vet Pathol; 1999 May; 36(3):228-36. PubMed ID: 10332831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of serotonin and bombesin in adenocarcinomas and neuroendocrine tumors of the colon.
    Seretis E; Gavrill A; Agnantis N; Golematis V; Voloudakis-Baltatzis IE
    Ultrastruct Pathol; 2001; 25(6):445-54. PubMed ID: 11783909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
    Sharma A; Comstock CE; Knudsen ES; Cao KH; Hess-Wilson JK; Morey LM; Barrera J; Knudsen KE
    Cancer Res; 2007 Jul; 67(13):6192-203. PubMed ID: 17616676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.